Vol.:(0123456789)
1 3
Cancer Chemotherapy and Pharmacology (2021) 88:563 https://doi.org/10.1007/s00280-021-04275-5
CORRECTION
Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
Shuo Yu
1,2· Yang Li
2· Hui Ren
2· Hong Zhou
2· Qian Ning
2· Xue Chen
2· Tinghua Hu
2· Lan Yang
2Published online: 15 April 2021
© Springer-Verlag GmbH Germany, part of Springer Nature 2021
Correction to:
Cancer Chemotherapy and Pharmacology (2021) 87:207–215
https:// doi. org/ 10. 1007/ s00280- 020- 04188-9
In the original publication of the article, the affiliation were mistakenly disordered. The correct affiliation is as follows Shuo Yu
1,2, Yang Li
2, Hui Ren
2, Hong Zhou
2, Qian Ning
2, Xue Chen
2, Tinghua Hu
2, Lan Yang
21
Department of General Surgery, The Second Affili- ated Hospital of Xi’an Jiaotong University, Xi’an, 710000, Shaanxi, China
2
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710000, Shaanxi, China
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article can be found online at https:// doi. org/ 10. 1007/
s00280- 020- 04188-9.
* Tinghua Hu
hutinghua0908@163.com
* Lan Yang
yanglandoc2017@163.com
1 Department of General Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi, China
2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi, China
